This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Prosidion Limited. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Jozsef Repasi: Innovator in Glycogen Phosphorylase Inhibition
Introduction
Jozsef Repasi is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that inhibit glycogen phosphorylase. His work is essential for advancing therapeutic options for various health conditions.
Latest Patents
Jozsef Repasi holds a patent for a novel pyrrolopyridine-2-carboxylic acid amide derivative. This compound is recognized for its utility as an inhibitor of glycogen phosphorylase. The patent outlines the unique formula of the compound, its therapeutic applications, and the processes for its production. The invention also includes novel intermediates that are crucial for synthesizing the compound.
Career Highlights
Jozsef Repasi is associated with Prosidion Limited, where he continues to innovate in the field of drug development. His expertise in medicinal chemistry has positioned him as a key player in the research and development of new therapeutic agents.
Collaborations
Jozsef has collaborated with András Szabó, contributing to the advancement of their shared research goals. Their partnership has fostered innovation and has led to the successful development of new compounds.
Conclusion
Jozsef Repasi's work in developing glycogen phosphorylase inhibitors showcases his commitment to advancing medical science. His contributions are vital for the future of therapeutic interventions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile